Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/40581
Full metadata record
DC FieldValueLanguage
dc.creatorWang, Chunyan-
dc.creatorLi, Wentao-
dc.creatorDrabek, Dubravka-
dc.creatorOkba, Nisreen M. A.-
dc.creatorvan Haperen, Rien-
dc.creatorOsterhaus, Albert D. M. E.-
dc.creatorvan Kuppeveld, Frank J. M.-
dc.creatorHaagmans, Bart L.-
dc.creatorGrosveld, Frank-
dc.creatorBosch, Berend-Jan-
dc.date.accessioned2020-05-05T14:32:25Z-
dc.date.available2020-05-05T14:32:25Z-
dc.date.issued2020-
dc.identifier.citationWANG, C. et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nature Communications, [S.l.], v. 11, 2020.pt_BR
dc.identifier.urihttps://www.nature.com/articles/s41467-020-16256-ypt_BR
dc.identifier.urihttp://repositorio.ufla.br/jspui/handle/1/40581-
dc.description.abstractThe emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.pt_BR
dc.languageen_USpt_BR
dc.publisherSpringer Naturept_BR
dc.rightsrestrictAccesspt_BR
dc.sourceNature Communicationspt_BR
dc.subjectCOVID-19 - Treatmentpt_BR
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)pt_BR
dc.subjectMonoclonal antibodypt_BR
dc.titleA human monoclonal antibody blocking SARS-CoV-2 infectionpt_BR
dc.typeArtigopt_BR
Appears in Collections:FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.